HIGHFDA DRUG

Greenstone Recalls Methylprednisolone Tablets Due to Dosing Error

Greenstone LLC recalled 3,456 cartons of methylprednisolone tablets on January 15, 2026. The recall follows reports of incorrect dosing information due to misapplied blister foil. Consumers should stop using the product immediately and contact their healthcare provider.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 15, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 15, 2026
Hazard Level
HIGH
Brands
METHYLPREDNISOLONE, Mylan Pharmaceuticals Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
METHYLPREDNISOLONE, Mylan Pharmaceuticals Inc.
Product type
Methylprednisolone Tablets
Model numbers
Lot # LG7675, Exp. Date Nov 2026
UPC codes
59762-0049, 59762-4440, 59762-0050, 59762-0051, 59762-4440-3, 59762-4440-2, 59762-0049-1, 59762-0050-1 +1 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 15, 2026

  2. Reported by FDA DRUG

    February 4, 2026

  3. RecallRadar source check

    February 11, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Greenstone Llc or your healthcare provider for guidance. Notification method: Letter

About This Product

Methylprednisolone tablets are corticosteroids used to treat a variety of conditions such as inflammation, allergies, and autoimmune disorders. Patients typically receive these medications through a prescription from healthcare providers.

Why This Is Dangerous

The hazard arises from the incorrect orientation of the blister foil, which misleads users about the correct dosage. This can lead to patients taking more or less medication than prescribed, impacting their treatment.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may face health risks if they continue using the affected product. The recall requires immediate action to prevent potential health issues linked to incorrect dosage.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the blister card.
  2. Verify the expiration date is November 2026.
  3. If you have lot number LG7675, your product is affected.

Where to find product info

The lot number and expiration date are typically located on the back or bottom of the blister card packaging.

What timeline to expect

Expect a refund processing time of approximately 4-6 weeks after returning the product.

If the manufacturer is unresponsive

  • Document all communication attempts with Greenstone LLC.
  • Consider contacting the FDA for further assistance.
  • Explore consumer protection agencies if further issues arise.

How to prevent similar issues

  • Always check for recalls on medications before use.
  • Be aware of labeling and dosage instructions on medication packaging.
  • Consult with healthcare providers for any medication concerns.

Documentation advice

Keep a record of any correspondence with the manufacturer and retain receipts or documentation regarding the purchase.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

This recall affects methylprednisolone tablets, USP Dosepak, 4 mg, distributed by Greenstone LLC. The product comes in a carton containing 21 tablets and has an NDC of 59762-4440-2. The affected lot number is LG7675, with an expiration date of November 2026.

Key Facts

  • Recall date: January 15, 2026
  • Quantity recalled: 3,456 cartons
  • Incorrect dosing information due to blister foil error
  • Contact Greenstone LLC for refund process

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot # LG7675
Exp. Date Nov 2026
UPC Codes
59762-0049
59762-4440
59762-0050
+6 more
Affected States
ALL
Report Date
February 4, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more